133 related articles for article (PubMed ID: 33342728)
1. Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort.
Chiatamone Ranieri S; Arleo MA; Trasarti S; Bizzoni L; Carmosino I; De Luca ML; Mohamed S; Mariggiò E; Scalzulli E; Rosati S; De Benedittis D; Colafigli G; Pepe S; Molica M; Scamuffa MC; Di Prima A; Ferretti A; Baldacci E; Mancini M; Santoro C; Vignetti M; Breccia M; Latagliata R
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e328-e333. PubMed ID: 33342728
[TBL] [Abstract][Full Text] [Related]
2. High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia.
Latagliata R; Montanaro M; Cedrone M; Di Veroli A; Spirito F; Santoro C; Leonetti Crescenzi S; Porrini R; Di Giandomenico J; Villivà N; Spadea A; Rago A; De Gregoris C; Romano A; Anaclerico B; De Muro M; Felici S; Breccia M; Montefusco E; Bagnato A; Cimino G; Majolino I; Mazzucconi MG; Alimena G; Andriani A;
Thromb Res; 2017 Aug; 156():168-171. PubMed ID: 28662484
[TBL] [Abstract][Full Text] [Related]
3. Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.
Buxhofer-Ausch V; Wolf D; Sormann S; Forjan E; Schimetta W; Gisslinger B; Heibl S; Krauth MT; Thiele J; Ruckser R; Gisslinger H
Eur J Haematol; 2021 Jan; 106(1):58-63. PubMed ID: 32909297
[TBL] [Abstract][Full Text] [Related]
4. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
[TBL] [Abstract][Full Text] [Related]
5. Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.
Buxhofer-Ausch V; Steurer M; Sormann S; Schloegl E; Schimetta W; Gisslinger B; Ruckser R; Gastl G; Gisslinger H
Eur J Haematol; 2016 Dec; 97(6):511-516. PubMed ID: 27037858
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
[TBL] [Abstract][Full Text] [Related]
7. Is the absence of JAK2 mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients.
Patriarca A; Pompetti F; Malizia R; Iuliani O; Di Marzio I; Spadano A; Dragani A
Blood Transfus; 2010 Jan; 8(1):21-7. PubMed ID: 20104275
[TBL] [Abstract][Full Text] [Related]
8. [Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients].
Angona A; Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Garcia-Pallarols F; Longarón R; Ancochea À; Besses C
Med Clin (Barc); 2015 Mar; 144(6):247-53. PubMed ID: 25192581
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
Sacchi S; Vinci G; Gugliotta L; Rupoli S; Gargantini L; Martinelli V; Baravelli S; Lazzarino M; Finazzi G
Haematologica; 2000 May; 85(5):492-5. PubMed ID: 10800165
[TBL] [Abstract][Full Text] [Related]
10. External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients.
Fu R; Xuan M; Lv C; Zhang L; Li H; Zhang X; Zhang D; Sun T; Xue F; Liu X; Liang H; Zhang L; Yang R
Eur J Haematol; 2014 Jun; 92(6):502-9. PubMed ID: 24460750
[TBL] [Abstract][Full Text] [Related]
11. Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.
Piccin A; Steurer M; Mitterer M; Blöchl EM; Marcheselli L; Pusceddu I; Marabese A; Bertozzi I; Corvetta D; Randi ML; Elli E; Pogliani EM; Veneri D; Perbellini O; Krampera M; Pacquola E; Gottardi M; Tiribelli M; Guella A; Innella B; Vivaldi P; De Biasi E; Sancetta R; Rocconi R; Bassan R; Gherlinzoni F; Pizzolo G; Gastl G; Cortelazzo S
Intern Emerg Med; 2015 Jun; 10(4):451-60. PubMed ID: 25585678
[TBL] [Abstract][Full Text] [Related]
12. Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results.
Latagliata R; Rago A; Spadea A; Santoro C; Carmosino I; Breccia M; Napoleone L; Fama A; Biondo F; Volpicelli P; Vozella F; Stefanizzi C; Petti MC; Alimena G; Mazzucconi MG
Int J Hematol; 2009 Nov; 90(4):486-491. PubMed ID: 19701677
[TBL] [Abstract][Full Text] [Related]
13. Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
Andriani A; Latagliata R; Anaclerico B; Spadea A; Rago A; Di Veroli A; Spirito F; Porrini R; De Muro M; Crescenzi Leonetti S; Villivà N; De Gregoris C; Montefusco E; Polverelli N; Santoro C; Breccia M; Cimino G; Majolino I; Mazzucconi MG; Vianelli N; Alimena G; Montanaro M; Palandri F
Am J Hematol; 2016 Mar; 91(3):318-21. PubMed ID: 26748894
[TBL] [Abstract][Full Text] [Related]
14. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.
Weston H; Cowell V; Grimmett K; Saal R; Jones M; Mills T; Gill D; Marlton P; Bird R; Mollee P
Intern Med J; 2011 May; 41(5):408-15. PubMed ID: 20681956
[TBL] [Abstract][Full Text] [Related]
16. Comparison between thrombotic risk scores in essential thrombocythemia and survival implications.
Santoro M; Accurso V; Mancuso S; Carlisi M; Raso S; Tarantino G; Di Piazza F; Perez A; Russo A; Siragusa S
Hematol Oncol; 2019 Oct; 37(4):434-437. PubMed ID: 31465530
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
Alvarez-Larrán A; Pereira A; Guglielmelli P; Hernández-Boluda JC; Arellano-Rodrigo E; Ferrer-Marín F; Samah A; Griesshammer M; Kerguelen A; Andreasson B; Burgaleta C; Schwarz J; García-Gutiérrez V; Ayala R; Barba P; Gómez-Casares MT; Paoli C; Drexler B; Zweegman S; McMullin MF; Samuelsson J; Harrison C; Cervantes F; Vannucchi AM; Besses C
Haematologica; 2016 Aug; 101(8):926-31. PubMed ID: 27175028
[TBL] [Abstract][Full Text] [Related]
18. Essential Thrombocythemia: One-Center Data in a Changing Disease.
Pirciulescu N; Gaman MA; Mihailescu M; Constantin C; Dragomir M; Dobrea C; Costache S; Ursuleac I; Coriu D; Crisan AM
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557000
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of thrombosis with increased platelet turnover in essential thrombocythemia].
Gao XP; Liu ZM; Li J; Han XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):165-7. PubMed ID: 16584616
[TBL] [Abstract][Full Text] [Related]
20. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
